BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,487,427 | -42.3% | 1,443,758 | -30.3% | 0.01% | -36.8% |
| Q2 2023 | $94,383,235 | -5.2% | 2,071,625 | -15.6% | 0.02% | -9.5% |
| Q1 2023 | $99,519,679 | +24.4% | 2,453,641 | +56.3% | 0.02% | +5.0% |
| Q4 2022 | $80,012,247 | +78.3% | 1,569,791 | +88.4% | 0.02% | +81.8% |
| Q3 2022 | $44,867,000 | -40.4% | 833,046 | -28.9% | 0.01% | -38.9% |
| Q2 2022 | $75,287,000 | -7.6% | 1,172,153 | +11.6% | 0.02% | +20.0% |
| Q1 2022 | $81,468,000 | -54.1% | 1,050,668 | -49.2% | 0.02% | +200.0% |
| Q4 2021 | $177,404,000 | +108.6% | 2,066,652 | +95.5% | 0.01% | -54.5% |
| Q3 2021 | $85,036,000 | +22.9% | 1,057,264 | +23.0% | 0.01% | +10.0% |
| Q2 2021 | $69,196,000 | +20.5% | 859,567 | +26.3% | 0.01% | +11.1% |
| Q1 2021 | $57,414,000 | -48.7% | 680,754 | -51.2% | 0.01% | 0.0% |
| Q4 2020 | $111,872,000 | +95.4% | 1,394,228 | +95.8% | 0.01% | -18.2% |
| Q3 2020 | $57,260,000 | -13.3% | 712,031 | -7.1% | 0.01% | -31.2% |
| Q2 2020 | $66,021,000 | +52.3% | 766,797 | +43.6% | 0.02% | +23.1% |
| Q1 2020 | $43,361,000 | -46.6% | 534,059 | -45.0% | 0.01% | -43.5% |
| Q4 2019 | $81,266,000 | +42.7% | 971,836 | +49.3% | 0.02% | +21.1% |
| Q3 2019 | $56,930,000 | -68.3% | 650,845 | -70.3% | 0.02% | -13.6% |
| Q2 2019 | $179,427,000 | +363.6% | 2,190,804 | +360.2% | 0.02% | +37.5% |
| Q1 2019 | $38,705,000 | -2.6% | 476,029 | -21.2% | 0.02% | +6.7% |
| Q4 2018 | $39,748,000 | +44.6% | 603,898 | +69.3% | 0.02% | +66.7% |
| Q3 2018 | $27,490,000 | -13.0% | 356,600 | -16.6% | 0.01% | -10.0% |
| Q2 2018 | $31,588,000 | +20.1% | 427,783 | +5.7% | 0.01% | +11.1% |
| Q1 2018 | $26,311,000 | -38.1% | 404,537 | -38.4% | 0.01% | -40.0% |
| Q4 2017 | $42,475,000 | +13.0% | 657,100 | +9.7% | 0.02% | +7.1% |
| Q3 2017 | $37,604,000 | -49.3% | 599,264 | -51.0% | 0.01% | -56.2% |
| Q2 2017 | $74,107,000 | +155.7% | 1,224,115 | +119.0% | 0.03% | +113.3% |
| Q1 2017 | $28,981,000 | -26.8% | 558,830 | -37.4% | 0.02% | -25.0% |
| Q4 2016 | $39,600,000 | -47.7% | 893,100 | -43.9% | 0.02% | -44.4% |
| Q3 2016 | $75,723,000 | -45.3% | 1,590,837 | -48.1% | 0.04% | -52.0% |
| Q2 2016 | $138,510,000 | +17.4% | 3,063,032 | +6.7% | 0.08% | +17.2% |
| Q1 2016 | $117,954,000 | -0.9% | 2,871,280 | -8.0% | 0.06% | +16.4% |
| Q4 2015 | $119,028,000 | +51.3% | 3,120,038 | +30.3% | 0.06% | +61.8% |
| Q3 2015 | $78,684,000 | -50.4% | 2,395,220 | +5.6% | 0.03% | -49.3% |
| Q2 2015 | $158,543,000 | -12.4% | 2,267,168 | -14.2% | 0.07% | -18.3% |
| Q1 2015 | $180,923,000 | +10.2% | 2,641,221 | +17.9% | 0.08% | +24.2% |
| Q4 2014 | $164,123,000 | -17.6% | 2,239,365 | -19.3% | 0.07% | -14.3% |
| Q3 2014 | $199,248,000 | -7.3% | 2,776,204 | -6.7% | 0.08% | -17.2% |
| Q2 2014 | $215,042,000 | -5.2% | 2,974,290 | -3.5% | 0.09% | -11.4% |
| Q1 2014 | $226,764,000 | +101.2% | 3,081,892 | +90.2% | 0.10% | +101.9% |
| Q4 2013 | $112,720,000 | -26.0% | 1,620,713 | -30.1% | 0.05% | -35.0% |
| Q3 2013 | $152,279,000 | -34.8% | 2,318,141 | -31.2% | 0.08% | -39.8% |
| Q2 2013 | $233,410,000 | – | 3,369,559 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |